https://bsky.app/profile/schellenberglab.bsky.socialhttps://bsky.app/profile/schellenberglab.bsky.social/post/3lqg65sug4c2l Topobexin is an inhibitor that targets Topoisomerase IIβ's ATPase domain—protecting the heart from anthracycline chemo damage without reducing anticancer power. Read our article about this potentially game-changer in cardio-oncology @natcomms.nature.com rdcu.be/en4ak. https://rdcu.be/en4ak30 May 2025 21:23 +0000at://did:plc:vonwikm5epk6uxsuou3zllko/app.bsky.feed.post/3lqg65sug4c2l